AI Summary of Peer-Reviewed Research

This page presents an AI-generated summary of a published research paper. The original authors did not write or review this article. [See full disclosure ↓]

Publishing process signals: STRONG — reflects the venue and review process. — venue and review process.

Tmem178 suppresses NLRP3 activation in osteoclasts

Research area:Biochemistry, Genetics and Molecular BiologyMolecular BiologyInflammasome and immune disorders

What the study found

Tmem178, a protein that limits calcium (Ca2+) entry by restraining store-operated calcium entry, suppresses NLRP3 inflammasome activation in osteoclasts, the bone-resorbing cells. The abstract states that this restraint also limits the bone-resorbing activity of osteoclasts.

Why the authors say this matters

The authors conclude that Tmem178 potently restricts Ca2+ influx in osteoclasts, and the study suggests this limits NLRP3 inflammasome activation in a cell type involved in bone resorption during inflammatory conditions.

What the researchers tested

The researchers examined NLRP3 abundance during osteoclastogenesis, the process by which osteoclasts form, and tested responses to lipopolysaccharide (LPS, a bacterial product) and nigericin, an NLRP3 activator. They compared macrophages with osteoclasts and lineage-committed osteoclast precursors, and also studied osteoclasts lacking Tmem178, wild-type osteoclasts exposed to high Ca2+ concentrations, and mice in vivo.

What worked and what didn't

NLRP3 abundance decreased during osteoclastogenesis but was restored by LPS treatment. LPS and nigericin activated the inflammasome in macrophages, but not in osteoclasts or their precursors; this difference was linked to abundant Tmem178 in osteoclasts. Inflammasome activation was robust in Tmem178-deficient osteoclasts and in wild-type osteoclasts exposed to high Ca2+, and Nlrp3 deletion rescued the osteopenic phenotype seen in Tmem178-/- mice.

What to keep in mind

The abstract does not describe specific experimental limitations. The findings are limited to the cell types and in vivo conditions described in the summary.

Key points

  • Tmem178 suppresses NLRP3 inflammasome activation in osteoclasts.
  • NLRP3 abundance falls during osteoclast formation but can be restored by LPS.
  • LPS and nigericin activated the inflammasome in macrophages, but not in osteoclasts or their precursors.
  • Inflammasome activation was strong in Tmem178-lacking osteoclasts and in osteoclasts exposed to high Ca2+.
  • Deleting Nlrp3 rescued the osteopenic phenotype in Tmem178-/- mice.

Disclosure

Research title:
Tmem178 suppresses NLRP3 activation in osteoclasts
Authors:
Khushpreet Kaur, Yael Alippe, C Wang, Nicholas P. Semenkovich, Mohamed Ghassan, Saumya Bhagat, Kunjan Khanna, Y S Li, Nitin Pokhrel, Timothy Peterson, Erica L. Scheller, Deborah J. Veis, Yousef Abu‐Amer, Roberta Faccio, Gabriel Mbalaviele
Institutions:
Washington University in St. Louis, Medical College of Wisconsin, Technologies pour la Santé, Shriners Hospitals for Children – St. Louis
Publication date:
2026-04-21
OpenAlex record:
View
AI provenance: This post was generated by OpenAI. The original authors did not write or review this post.